Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thera P Links

Showing results (221-230 of 230) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 230 results.
Journal of the National Cancer Institute|September 29, 2022
Cancer risks by sex and variant type in PTEN hamartoma tumor syndromeLinda A J Hendricks, Nicoline Hoogerbrugge, Arjen R Mensenkamp, et al.
European Journal of Endocrinology|December 20, 2017
Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional studyMarloes Nies, Bernadette L Dekker, Esther Sulkers, et al.
Thyroid : Official Journal of the American Thyroid Association|February 22, 2020
Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid CarcinomaMarloes Nies, Astrid E P Cantineau, Eus G J M Arts, et al.
Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
JAMA Network Open|August 10, 2019
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyHartmut P H Neumann, Uliana Tsoy, Irina Bancos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 28, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
The Lancet. Oncology|April 22, 2014
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based studyFrederic Castinetti, Xiao-Ping Qi, Martin K Walz, et al.
The Lancet. Diabetes & Endocrinology|January 21, 2019
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective studyFrederic Castinetti, Steven G Waguespack, Andreas Machens, et al.
Endocrine-Related Cancer|May 12, 2018
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumorsTobias Krauss, Alfonso Massimiliano Ferrara, Thera P Links, et al.
Endocrine-Related Cancer|April 9, 2025
Genotype-specific neoplastic risk profiles in patients with VHL diseaseAthina Ganner, Alfonso Massimiliano Ferrara, Peggy Sekula, et al.
Pageof 23

Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
Journal of the National Cancer Institute|September 29, 2022
Cancer risks by sex and variant type in PTEN hamartoma tumor syndromeLinda A J Hendricks, Nicoline Hoogerbrugge, Arjen R Mensenkamp, et al.
European Journal of Endocrinology|December 20, 2017
Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional studyMarloes Nies, Bernadette L Dekker, Esther Sulkers, et al.
Thyroid : Official Journal of the American Thyroid Association|February 22, 2020
Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid CarcinomaMarloes Nies, Astrid E P Cantineau, Eus G J M Arts, et al.
Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
JAMA Network Open|August 10, 2019
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyHartmut P H Neumann, Uliana Tsoy, Irina Bancos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 28, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
The Lancet. Oncology|April 22, 2014
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based studyFrederic Castinetti, Xiao-Ping Qi, Martin K Walz, et al.
The Lancet. Diabetes & Endocrinology|January 21, 2019
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective studyFrederic Castinetti, Steven G Waguespack, Andreas Machens, et al.
Endocrine-Related Cancer|May 12, 2018
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumorsTobias Krauss, Alfonso Massimiliano Ferrara, Thera P Links, et al.
Endocrine-Related Cancer|April 9, 2025
Genotype-specific neoplastic risk profiles in patients with VHL diseaseAthina Ganner, Alfonso Massimiliano Ferrara, Peggy Sekula, et al.
Pageof 23